Advanced Health Intelligence Ltd
MYZQF
$0.004
-$0.001-20.00%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -66.10% | -67.24% | 389.95% | 396.02% | 128.10% |
| Total Other Revenue | -97.98% | -98.06% | -78.64% | -80.27% | 691.58% |
| Total Revenue | -91.39% | -91.68% | 561.86% | 567.35% | 423.85% |
| Cost of Revenue | 30.38% | 25.97% | 23.40% | 24.56% | -76.26% |
| Gross Profit | -424.64% | -406.95% | -18.40% | -19.52% | 94.20% |
| SG&A Expenses | 45.20% | 40.30% | -41.42% | -40.86% | 6.12% |
| Depreciation & Amortization | 40.95% | 36.47% | -19.69% | -18.91% | -- |
| Other Operating Expenses | -- | -- | -124.24% | -126.36% | -- |
| Total Operating Expenses | 39.11% | 34.43% | -33.09% | -32.45% | -55.40% |
| Operating Income | -97.40% | -90.74% | 34.93% | 34.31% | 68.33% |
| Income Before Tax | -96.22% | -89.60% | -52.88% | -54.33% | 77.05% |
| Income Tax Expenses | -- | -- | 26.97% | 28.19% | -- |
| Earnings from Continuing Operations | -96.22% | -89.60% | -48.77% | -50.18% | 75.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -96.22% | -89.60% | -48.77% | -50.18% | 75.64% |
| EBIT | -97.40% | -90.74% | 34.93% | 34.31% | 68.33% |
| EBITDA | -99.33% | -92.60% | 34.14% | 35.91% | 69.32% |
| EPS Basic | -41.25% | -37.35% | -18.18% | -18.70% | 78.49% |
| Normalized Basic EPS | -51.06% | -44.90% | 36.67% | 36.26% | 75.39% |
| EPS Diluted | -41.25% | -37.35% | -18.18% | -18.70% | 78.49% |
| Normalized Diluted EPS | -51.06% | -44.90% | 36.67% | 36.26% | 75.39% |
| Average Basic Shares Outstanding | 38.27% | 38.27% | 26.34% | 26.34% | 13.52% |
| Average Diluted Shares Outstanding | 38.27% | 38.27% | 26.34% | 26.34% | 13.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
